Smoking Cessation Study | American Lung Association

Location Select your location

Clinical Trials

Smoking Cessation Study

Institution:

University of California, Los Angeles (UCLA)

Type:

Individual Site

Purpose:

This study is a double-blind, randomized clinical trial using a two group medication design consisting of the combination of VAR (1 mg twice daily) + NTX (50 mg once daily) and VAR (1 mg twice daily) + PLA (matched to NTX), for smoking cessation in a sample of heavy drinking daily smokers who want to quit smoking and reduce drinking.

Dates:

April 1, 2016 - March 31, 2019

Disease:

Asthma

Register:

https://www.surveymonkey.com/r/SmokingCessationStudy

Contact:

Yaneli Arevalo
310-206-6756
raylab@psych.ucla.edu

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.